全文获取类型
收费全文 | 43325篇 |
免费 | 2734篇 |
国内免费 | 871篇 |
专业分类
耳鼻咽喉 | 226篇 |
儿科学 | 445篇 |
妇产科学 | 318篇 |
基础医学 | 3734篇 |
口腔科学 | 872篇 |
临床医学 | 4059篇 |
内科学 | 4674篇 |
皮肤病学 | 842篇 |
神经病学 | 1866篇 |
特种医学 | 1042篇 |
外国民族医学 | 5篇 |
外科学 | 3511篇 |
综合类 | 6764篇 |
现状与发展 | 3篇 |
预防医学 | 3999篇 |
眼科学 | 378篇 |
药学 | 7657篇 |
4篇 | |
中国医学 | 2886篇 |
肿瘤学 | 3645篇 |
出版年
2024年 | 303篇 |
2023年 | 499篇 |
2022年 | 860篇 |
2021年 | 1140篇 |
2020年 | 751篇 |
2019年 | 3259篇 |
2018年 | 2823篇 |
2017年 | 1573篇 |
2016年 | 974篇 |
2015年 | 1263篇 |
2014年 | 2777篇 |
2013年 | 2414篇 |
2012年 | 2138篇 |
2011年 | 2244篇 |
2010年 | 2182篇 |
2009年 | 2679篇 |
2008年 | 1809篇 |
2007年 | 2680篇 |
2006年 | 2367篇 |
2005年 | 1871篇 |
2004年 | 927篇 |
2003年 | 1036篇 |
2002年 | 820篇 |
2001年 | 676篇 |
2000年 | 591篇 |
1999年 | 464篇 |
1998年 | 444篇 |
1997年 | 379篇 |
1996年 | 364篇 |
1995年 | 332篇 |
1994年 | 294篇 |
1993年 | 210篇 |
1992年 | 213篇 |
1991年 | 198篇 |
1990年 | 143篇 |
1989年 | 139篇 |
1988年 | 107篇 |
1987年 | 145篇 |
1986年 | 138篇 |
1985年 | 421篇 |
1984年 | 468篇 |
1983年 | 326篇 |
1982年 | 318篇 |
1981年 | 246篇 |
1980年 | 255篇 |
1979年 | 168篇 |
1978年 | 94篇 |
1977年 | 96篇 |
1976年 | 84篇 |
1974年 | 75篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
A. Balhareth I.S. Reynolds J.G. Solon E. Gibbons Harte F. Boland J.M. OSullivan J.P. Burke D. Little D.A. McNamara 《Transplantation proceedings》2018,50(10):3434-3439
Background
Renal transplantation is associated with an increased risk of neoplasia, including colorectal cancer (CRC). Advances in surgical techniques and immunosuppressive medications have resulted in increased survival rates of both patients and grafts, but the incidence of CRC in the Irish renal transplant population is currently unknown. The aim of this study is to review the incidence of CRC in the Irish renal transplant population and compare it to the general population.Methods
A retrospective review of a prospectively maintained database of all renal transplant recipients in Ireland between January 1980 and July 2017 was performed.Results
Thirty-three out of 4230 transplant recipients (men = 20, women = 13) developed CRC subsequent to transplantation and were eligible for inclusion in the series. The mean age at transplantation was 51.5 years, with patients developing CRC on average 10.9 years post-transplantation; 6.1% (n = 2/33) had stage IV disease at diagnosis. The majority of patients (87.8%) had a pathologic T stage of T3/T4 and 45.5% had involvement of locoregional lymph nodes (N1/N2); 42.4% also had a mucinous component at histopathologic assessment. The incidence of CRC was higher in the transplant population compared to the general population.Conclusion
This is the first population-based assessment of CRC development in the Irish renal transplant population. Our data suggest that Irish transplant recipients have an increased risk of being diagnosed with a more advanced tumor than the general population, with most being diagnosed almost a decade after transplantation. This highlights the need for increased awareness among patients and clinicians and the potential need for coordinated lifelong surveillance of this patient population to ensure early detection and treatment. 相似文献82.
W.J. Bush J.P. Davis M.A. Maluccio C.A. Kubal J.B. Salisbury R.S. Mangus 《Transplantation proceedings》2018,50(10):3501-3507
Background
Patients with cirrhosis and end-stage liver disease (ESLD) develop severe nutrition deficits that affect morbidity and mortality. Laboratory measures of nutrition fail to fully assess clinical deficits in muscle mass and fat stores. This study employs computed tomography imaging to assess muscle mass and subcutaneous and visceral fat stores in patients with ESLD.Methods
This 1:1 case-control study design compares ESLD patients with healthy controls. Study patients were selected from a database of ESLD patients using a stratified method to assure a representative sample based on age, body mass index (BMI), sex, and model for end-stage liver disease score (MELD). Control patients were trauma patients with a low injury severity score (<10) who had a computed tomography scan during evaluation. Cases and controls were matched for age ± 5 years, sex, and BMI ± 2.Results
There were 90 subjects and 90 controls. ESLD patients had lower albumin levels (P < .001), but similar total protein levels (P = .72). ESLD patients had a deficit in muscle mass (?19%, P < .001) and visceral fat (?13%, P < .001), but similar subcutaneous fat (?1%, P = .35). ESLD patients at highest risk for sarcopenia included those over age 60, BMI<25.0, and female sex. We found degree of sarcopenia to be independent of model for end-stage liver disease score.Conclusions
These results support previous research demonstrating substantial nutrition deficits in ESLD patients that are not adequately measured by laboratory testing. Patients with ESLD have significant deficits of muscle and visceral fat stores, but a similar amount of subcutaneous fat. 相似文献83.
E. Wlodarczyk Z. Wlodarczyk L. Paczek A. Szymanska M. Glyda A. Adamowicz G. Baczyk A. Ulatowska 《Transplantation proceedings》2018,50(6):1900-1903
Kidney transplantation is an optimal method of renal replacement therapy in patients with phase V chronic kidney disease. Elderly patients (older than 60 years) with a kidney transplant create a significant and constantly growing pool of patients with this type of organ transplantation. In this group of patients, long-term care should be particularly stringent and vigilant. Apart from typical conditions associated with chronic kidney disease and possible post-transplant complications as well as side effects of immunosuppressive treatment, the patient also experiences changes and limitations associated with the progress of age and diseases typical for old age, characterized by a higher risk of infection, and changed pharmacokinetics/pharmacodynamics. Undoubtedly, patients should remain under the medical care of qualified transplantologists, but constant cooperation with a general practitioner and geriatrician would be of added value. Study results show that although most of the elderly kidney recipients have constant contact with their general practitioners, and almost half of them use private care, contribution of the geriatrician to the transplant care system is unsatisfactory, and elderly kidney recipients would expect more extensive outpatient care. 相似文献
84.
Marina M.K. Bond Marisa M.K. Bond A. Sehn V.H. Dias T.L. Said C.C. dos Santos M.A. Finger A.M.G. Santos J.M.R. Neto 《Transplantation proceedings》2018,50(3):809-814
Introduction
Cytomegalovirus (CMV) infection is a relevant cause of morbidity and mortality in transplantation patients. Its major incidence is in the first year and viral replication is related to acute rejection, survival reduction, and graft vascular disease.Objective
This study aims to evaluate retrospectively whether a high dose of calcineurin inhibitors correlates with CMV-positive polymerase chain reaction (PCR), need for treatment, and death in cardiac transplantation patients.Methods
This is a case-control study including patients who underwent transplantation between 2014 and 2016. They were separated into two groups (positive or negative PCR) and evaluated for dosage serum levels of cyclosporine and tacrolimus. Patients were classified with adequate dose of immunosuppressant or high dose, and was analyzed that there was any association with those and positive CMV-PCR, need for treatment for CMV, and deaths. For statistical analysis, the Student t test was used for the quantitative variables and the Fisher’s Exact Test for qualitative variables. To show CMV-free survival, the Kaplan-Meier curve was used. The level of significance was set at 5%.Results
CMV-positive PCR in the sample was 72% for a total of 50 individuals. Positive PCR correlated with a high dose of calcineurin inhibitors in a statistically significant way (P = .002), as did a high dose of cyclosporine (P = .004); however, a high dose of tacrolimus had no such association (P = .17). When a high dose was assessed with a need for treatment, the chance of needing treatment increased more than eight times (P = .024; odds ratio = 8.25; 95% CI = 1.33 to 51.26), which was different from results found with high-dose tacrolimus (P = 1.0). However, no significant association was found in relation to deaths.Conclusions
Tacrolimus serum levels showed no association with CMV-PCR, which was different from serum cyclosporine, which showed association with CMV-PCR positivity, increasing the need for treatment approximately 8-fold, without association with death. 相似文献85.
A. Kurek J. Pawlicki A. Lekstan D. Bula L. Cierpka A. Więcek R. Król 《Transplantation proceedings》2018,50(7):1985-1991
Background
Liver transplantation (LTx) is one of the most complex transplant procedures. The aim of the present study was to determine whether the learning process can be observed after the introduction of LTx in a center with extensive previous experience in renal transplantation.Methods
This retrospective analysis included 264 primary LTx procedures performed with the piggyback technique (2005–2016). The procedures were divided into 4 equal groups. The characteristics of the recipients, data related to the surgery, and the postoperative course and complications were analyzed.Results
We observed a significant reduction in surgical time and in the anhepatic phase duration between Group 1 and the other groups (median surgical time was 455 minutes vs 415 minutes, 410 minutes and 387 minutes, respectively, P < .05; median anhepatic phase duration was 75 min vs 60 min, 62 min, 60 min, respectively, P < .05). There was a decrease in the number of transfused blood units (median in Group 1 of 6 packs vs 3 packs in Group 4, P < .05) and a decrease in blood recovered from the operating field using the Cell Saver system (median in Group 1 of 1570 mL vs 1057 mL, 1123 mL, and 1045 mL, respectively, P < .05). A significant reduction in the number of hemorrhages was found (1.5% in Group 4 vs 13.6%, 10.6%, and 7.6% in the other groups P < .05). The remaining studied parameters were not statistically significant.Conclusions
Extensive previous transplantation experience affected the lack of typical features of the learning process. 相似文献86.
B. Szygula-Jurkiewicz W. Szczurek M. Skrzypek P. Nadziakiewicz L. Siedlecki M. Zakliczynski M. Gasior M. Zembala 《Transplantation proceedings》2018,50(7):2095-2099
Background
Red blood cell markers (RBCM) have been found to be predictors of mortality in various populations. However, there is no information regarding the association between the values of RBCM and long-term outcomes after orthotopic heart transplantation (OHT).The aim of this study was to assess whether the values of inflammatory markers and RBCM obtained directly before OHT are associated with mortality in patients diagnosed as having end-stage heart failure undergoing OHT.Methods
We retrospectively analyzed data of 173 nonanemic adult patients diagnosed as having end-stage heart failure undergoing primary OHT between 2007 and 2014. Clinical and laboratory data were obtained at the time of admission for the OHT. RBCM were analyzed using an automated blood counter (Sysmex XS-1000i and XE-2100, Sysmex Corporation, Kobe, Japan).Results
Mean age of the patients was 54 (41–59) and 72% of them were male. During the observation period, the mortality rate was 32%. Multivariable analysis of Cox proportional hazard confirmed that elevated pretransplantation red blood cell distribution width value (hazard ratio [HR], 1.38 [1.25–1.48], P < .001) was the sole independent predictor of death during long-term follow-up. Other red blood cell distribution width such as mean corpuscular volume, mean corpuscular hemoglobin concentration, and mean corpuscular hemoglobin (HR, 0.88 [0.84–0.91]; P < .001; HR, 0.75 [0.53–1.05]; P < .05; HR, 0.78 [0.64–0.96]; P < .05, respectively) had predictive value in univariable analysis.Conclusions
In summary, we have demonstrated that elevated red blood cell distribution width immediately before OHT is an independent predictor of all-cause mortality in heart transplant recipients. Other factors associated with posttransplantation mortality include lower values of mean corpuscular volume, mean corpuscular hemoglobin, and mean corpuscular hemoglobin concentration. 相似文献87.
Rikkunshito (TJ-43), an eight-component traditional Japanese herbal medicine, has been used in clinics for gastritis, vomiting, and appetite loss. We investigated the effects of TJ-43 on the amelioration of appetite loss in the surgical-exposed model of murine cardiac allograft transplantation. CBA mice underwent transplantation of a CBA (syngeneic group) or C57BL/6 heart (allogeneic group) and received oral administration of 2 g/kg/d of TJ-43 from the day of transplantation until 7 days afterward. The amount of food intake (FI) and weight change after operation were recorded from 1 to 28 postoperative days. The allogeneic group had less average amounts of FI for 1 week compared with the syngeneic group (FI was 1.90 ± 0.43 g and 2.66 ± 0.46 g, respectively). Average FIs between the syngeneic and allogeneic groups with TJ-43 for 1 week were 2.36 ± 0.44 g and 2.30 ± 0.13 g, respectively, and those with distilled water were 2.66 ± 0.46 g and 1.90 ± 0.43 g, respectively, suggesting that exposure with TJ-43 tended to ameliorate the reduction of FI. Similarly, the effect on the amelioration of average FI in syngeneic and allogeneic groups exposed for 2 weeks was confirmed. However, exposure to with TJ-43 had no effects on FI after 4 weeks. TJ-43 could prevent reduction of average FI induced by the surgical-exposed model of murine cardiac allograft transplantation. 相似文献
88.
Shigyakusan (also known as Tsumura Japan [TJ]-35) is composed of peony, bitter orange, licorice, and Bupleuri radix is used for cholecystitis and gastritis as an anti-inflammatory agent. We investigated the effect of TJ-35 on alloimmune response in a murine heart transplantation model. CBA mice that underwent transplantation of a C57BL/6 (B6) heart were assigned to four groups: no treatment, TJ-35–exposed, each component–exposed, or each component missing–exposed. The four groups above each received oral administration of TJ-35, each component, or TJ-35 with each component missing from the day of transplantation until 7 days, respectively. Untreated CBA recipients rejected B6 cardiac grafts acutely (median survival time [MST], 7 days). TJ-35–exposed CBA recipients had significantly prolonged B6 allograft survival (MST, 20.5 days). However, MSTs of CBA recipients that had been administered each component and TJ-35 with each component missing did not reach that of TJ-35–exposed recipients. Adoptive transfer of CD4+ splenocytes from TJ-35–exposed primary allograft recipients resulted in significant prolonged allograft survival in naïve secondary recipients (MST, 63 days). Flow cytometry studies showed that the percentage of CD4+CD25+Foxp3+ cell population was increased in TJ-35–exposed CBA recipients. In conclusion, TJ-35–induced prolongation of fully allogeneic cardiac allografts and may generate regulatory CD4+CD25+Foxp3+ cells in our model. The effect seemed to require all components of TJ-35. 相似文献
89.
J.Y. Park M.H. Kim E.J. Bae S. Kim D.K. Kim K.W. Joo Y.S. Kim J.P. Lee Y.H. Kim C.S. Lim 《Transplantation proceedings》2018,50(4):1068-1073
Background
Comorbid conditions are important in the survival of kidney transplant recipients. The weights assigned to comorbidities to predict survival may vary based on the type of index disease and advances in the management of comorbidities. We aimed to develop a modified Charlson comorbidity index (CCI) in renal allograft recipients (mCCI-KT), thereby improving risk stratification for mortality.Methods
A total of 3765 recipients in a multicenter cohort were included to develop a comorbidity score. The weights of the comorbidities, per the CCI, were recalibrated using a Cox proportional hazards model.Results
Peripheral vascular disease, liver disease, myocardial infarction, and diabetes in the CCI were selected from the Cox proportional hazards model. Thus, the mCCI-KT included 4 comorbidities with recalibrated severity weights. Whereas the CCI did not discriminate for survival, the mCCI-KT provided significant discrimination for survival using the Kaplan-Meier method and Cox regression analysis. The mCCI-KT showed modest increases in c-statistics (0.54 vs 0.52, P = .001) and improved net mortality risk reclassification by 16.3% (95% confidence interval, 3.2–29.4; P = .015) relative to the CCI.Conclusion
The mCCI-KT stratifies the risk for mortality in renal allograft recipients better than the CCI, suggesting that it may be a preferred index for use in clinical practice. 相似文献90.
E.C. de Ataide S. Reges Perales M.A. de Oliveira Peres L. Bastos Eloy da Costa F. Quarella F.G. Valerini F. Chueiri Neto R. Silveira Bello Stucchi I. de Fátima Santana Ferreira Boin 《Transplantation proceedings》2018,50(2):476-477